SENOLYS
Live / Registered — Registered (as of 31 Oct 2023)
What this means for you
Registered since 31 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90591143
- Registration number
- 7208145
- Mark type
- Stylized text
- Filed
- 19 Mar 2021
- Published for opposition
- 04 Apr 2023
- Registered
- 31 Oct 2023
- Attorney of record
- Chris P. Cheng
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Seragon Pharmaceuticals Inc., Irvine, CA, US
- Seragon Pharmaceuticals Inc., Irvine, CA, US
- Seragon Pharmaceuticals Inc., Irvine, CA, US
Prosecution history
- 09 Jul 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 29 Sept 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Sept 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Sept 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Aug 2023 — USE AMENDMENT FILED
- 24 Jul 2023 — DIVISIONAL REQUEST RECEIVED
- 31 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Aug 2023 — TEAS STATEMENT OF USE RECEIVED
- 30 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED